Case Report
BibTex RIS Cite

Over Tümörlerinin Tanı Ve Takibinde Tümör Marker'larının Yeri Ve Değeri

Year 1988, Volume: 41 Issue: 1, 67 - 76, 31.03.1988

Sevgi Tezcan

https://izlik.org/JA74WJ92HK

Abstract

Kadm genital organ kanserlerinin erken teshisinde kullamlan ve gelistirilen özel muayene mctodlarl vo laboratuvar metodlarma ragmen davrams özellikleri transvajinal nedeniyle erken teshiste en fazla güçlükle karsllasllan grup, over tümörleridir. Erken teshis için vajinal yoldan uygulanan diagnostik testler fevkalade Slnn•lldmr. Semptomlar ise genellikle spesifik dežildir. Bu nedenle teshis cdilen malign over tümörleri genellikle ileri klinik safhada olrnaktadlr. Dolaylswla tedavi sansl azalmaktachr. Son Ylllarda çesitli tümör marker'lerinin over karsinomlannda da arastlrnlmasl teshiste ve tedavinin takibinde kullanllabilirliýini düsündiirmüstür. Özellikle en dodermal orijinli over karsinomlarmm teshis, tedavinin takibi, remisyon ve rekürrenslerin kontrolu iÇin uygun ve güvenilir bir yöntem olabilirler.

Keywords

yumurtalık tümör genital karsinom kadın

Ethical Statement

-

Supporting Institution

-

Project Number

-

Thanks

-

References

  • 1. Disaia P.J., Morcow C.P., Hoverback B.J. : CEA in cancer of the female rep roductiv system. Serial plasma values correlated with disease state. Cancer, 1977, 39; 2365.
  • 2. Gold P., Freedman S.D. : Demonstration of tumor spesific antigens in human colonic carcinoma by immunological tolerance and absorbtion tecnique. J. Exp, Med. 1965, 121; 439-462.
  • 3. Gold p. , and Freedman J.O. : Spesific CEA' sof the human digestive system. J. Exp. Med. 1965, 121 : 467-481.
  • 4. Lau, L.H., Linking B.A., Susan E. : AFP Am. J. Obstet. Gynecol. 124 : 533-1976.
  • 5. Laurence D.J.R., and Neville A.M. : Foetal antigens and their role in the nosis and clinical management of human neoplasias. A review. Br. J. Cancer. 1972* 26-336-335.
  • 6. Le Gergo P. Krupey J., and Hansen H.J. : Demonstration of an antigen common to several varieties of neoplasia. N. Eng. J. Med. 1971, 285; 138-141.
  • 7. Meeker WR, Kashmiri R, Hunter L, Clapp W and Griffen W.O. : Clinical evaluation of carsinoembrionic antigen test. Arch. Sura 1973, 107; 266-274.
  • 8. Reynosa G., Chu T M s, Guinan P. and Murphy G.P. : Carsinoembrionic antigen in patients with tumors of the urogenital tract. Cancer 1972 30; 1-4.
  • 9. Reynosa G., Chu T,M., Holyoke D, Cohen E., Nemota T., Wang J.T., Chuang J., Murphy G.P. : CEA in patients with different cancers. JAMA, 1972, 220 361-365.
  • 10. Van Nagel J.R. Jr, Meeker W.R., Parkêr J.C., Harralson J.D. CEA in patients with gynecological malginancy. Cancer, 1975, 36; 1372.
  • 11. Pletich QR., Van Nagel J.R. Jr. and Goldenberg D.M. : Characterization og carsinoembrionic antigen (CEA) in the plasma and the tumors of patients with ovarian cancer. Proc. Am. Assoc. Cancer Res. 1974. 15 : 140.
  • 12. Stevens D.P., Mackey R, : Increased CEA in heavy cigarette smokers. Lancet, 1973; 2; 1238.
  • 13. Rto Fl., Kurikara S., Nishimura C. : Serum CEA in patients with carcinoma of the cervix. Obstet. Gynecol. 1978, 51; 468.
  • 14. Serokin S.S , Kupchik I-I.Z. : Clinical comparison of the radioimmunoassays for CEA. Immunol. Common. 1972, 1 : 11-24.
  • 15. Yavuz H., Tezcan S., Tanbuga G. : Kachn genital organ karsinomlarmda serum lactat dehidrogenaz enzim aktivitesi. Ankara TIP Bültenij 1982 C. 4, S. 2, 161-166.
  • 16. William's Obstetrics. 16th Ed., 1980, p : 149, 261, 348.

The Role and Value of Tumor Markers in the Diagnosis and Follow-up of Ovarian Tumors

Year 1988, Volume: 41 Issue: 1, 67 - 76, 31.03.1988

Sevgi Tezcan

https://izlik.org/JA74WJ92HK

Abstract

Although there are many specific laboratory and phisycal examination methods in diagnose of women's genital tumors, the ovarian tumors have some difficulties in early diagnose because of the location. In ovarian tumors the symptoms are not specific. So, the stage is high, when the excite diagnose was made up, and the chance of the rapy becomes very low. Recent years, the use of tumor markers in diagnose and in the management of therapy in ovarian carcinomas was begun to discuss. Maybe the idea is usefull specifically in diag nose and management of endodermal originated ovarian carcinomas

Keywords

ovarian tumor genital carsinoma female

Project Number

-

References

  • 1. Disaia P.J., Morcow C.P., Hoverback B.J. : CEA in cancer of the female rep roductiv system. Serial plasma values correlated with disease state. Cancer, 1977, 39; 2365.
  • 2. Gold P., Freedman S.D. : Demonstration of tumor spesific antigens in human colonic carcinoma by immunological tolerance and absorbtion tecnique. J. Exp, Med. 1965, 121; 439-462.
  • 3. Gold p. , and Freedman J.O. : Spesific CEA' sof the human digestive system. J. Exp. Med. 1965, 121 : 467-481.
  • 4. Lau, L.H., Linking B.A., Susan E. : AFP Am. J. Obstet. Gynecol. 124 : 533-1976.
  • 5. Laurence D.J.R., and Neville A.M. : Foetal antigens and their role in the nosis and clinical management of human neoplasias. A review. Br. J. Cancer. 1972* 26-336-335.
  • 6. Le Gergo P. Krupey J., and Hansen H.J. : Demonstration of an antigen common to several varieties of neoplasia. N. Eng. J. Med. 1971, 285; 138-141.
  • 7. Meeker WR, Kashmiri R, Hunter L, Clapp W and Griffen W.O. : Clinical evaluation of carsinoembrionic antigen test. Arch. Sura 1973, 107; 266-274.
  • 8. Reynosa G., Chu T M s, Guinan P. and Murphy G.P. : Carsinoembrionic antigen in patients with tumors of the urogenital tract. Cancer 1972 30; 1-4.
  • 9. Reynosa G., Chu T,M., Holyoke D, Cohen E., Nemota T., Wang J.T., Chuang J., Murphy G.P. : CEA in patients with different cancers. JAMA, 1972, 220 361-365.
  • 10. Van Nagel J.R. Jr, Meeker W.R., Parkêr J.C., Harralson J.D. CEA in patients with gynecological malginancy. Cancer, 1975, 36; 1372.
  • 11. Pletich QR., Van Nagel J.R. Jr. and Goldenberg D.M. : Characterization og carsinoembrionic antigen (CEA) in the plasma and the tumors of patients with ovarian cancer. Proc. Am. Assoc. Cancer Res. 1974. 15 : 140.
  • 12. Stevens D.P., Mackey R, : Increased CEA in heavy cigarette smokers. Lancet, 1973; 2; 1238.
  • 13. Rto Fl., Kurikara S., Nishimura C. : Serum CEA in patients with carcinoma of the cervix. Obstet. Gynecol. 1978, 51; 468.
  • 14. Serokin S.S , Kupchik I-I.Z. : Clinical comparison of the radioimmunoassays for CEA. Immunol. Common. 1972, 1 : 11-24.
  • 15. Yavuz H., Tezcan S., Tanbuga G. : Kachn genital organ karsinomlarmda serum lactat dehidrogenaz enzim aktivitesi. Ankara TIP Bültenij 1982 C. 4, S. 2, 161-166.
  • 16. William's Obstetrics. 16th Ed., 1980, p : 149, 261, 348.
There are 16 citations in total.

Details

Primary Language English
Subjects Obstetrics and Gynaecology
Journal Section Case Report
Authors

Sevgi Tezcan This is me

Project Number -
Publication Date March 31, 1988
IZ https://izlik.org/JA74WJ92HK
Published in Issue Year 1988 Volume: 41 Issue: 1

Cite

APA Tezcan, S. (1988). The Role and Value of Tumor Markers in the Diagnosis and Follow-up of Ovarian Tumors. Ankara Üniversitesi Tıp Fakültesi Mecmuası, 41(1), 67-76. https://izlik.org/JA74WJ92HK
AMA 1.Tezcan S. The Role and Value of Tumor Markers in the Diagnosis and Follow-up of Ovarian Tumors. Ankara Üniversitesi Tıp Fakültesi Mecmuası. 1988;41(1):67-76. https://izlik.org/JA74WJ92HK
Chicago Tezcan, Sevgi. 1988. “The Role and Value of Tumor Markers in the Diagnosis and Follow-up of Ovarian Tumors”. Ankara Üniversitesi Tıp Fakültesi Mecmuası 41 (1): 67-76. https://izlik.org/JA74WJ92HK.
EndNote Tezcan S (March 1, 1988) The Role and Value of Tumor Markers in the Diagnosis and Follow-up of Ovarian Tumors. Ankara Üniversitesi Tıp Fakültesi Mecmuası 41 1 67–76.
IEEE [1]S. Tezcan, “The Role and Value of Tumor Markers in the Diagnosis and Follow-up of Ovarian Tumors”, Ankara Üniversitesi Tıp Fakültesi Mecmuası, vol. 41, no. 1, pp. 67–76, Mar. 1988, [Online]. Available: https://izlik.org/JA74WJ92HK
ISNAD Tezcan, Sevgi. “The Role and Value of Tumor Markers in the Diagnosis and Follow-up of Ovarian Tumors”. Ankara Üniversitesi Tıp Fakültesi Mecmuası 41/1 (March 1, 1988): 67-76. https://izlik.org/JA74WJ92HK.
JAMA 1.Tezcan S. The Role and Value of Tumor Markers in the Diagnosis and Follow-up of Ovarian Tumors. Ankara Üniversitesi Tıp Fakültesi Mecmuası. 1988;41:67–76.
MLA Tezcan, Sevgi. “The Role and Value of Tumor Markers in the Diagnosis and Follow-up of Ovarian Tumors”. Ankara Üniversitesi Tıp Fakültesi Mecmuası, vol. 41, no. 1, Mar. 1988, pp. 67-76, https://izlik.org/JA74WJ92HK.
Vancouver 1.Tezcan S. The Role and Value of Tumor Markers in the Diagnosis and Follow-up of Ovarian Tumors. Ankara Üniversitesi Tıp Fakültesi Mecmuası [Internet]. 1988 Mar. 1;41(1):67-76. Available from: https://izlik.org/JA74WJ92HK